Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the second dose of the Pfizer vaccine, according to a study released today by the Centers for Disease Control and Prevention.

Israel initiated a national vaccination campaign using the Pfizer vaccine in December, prioritizing people over 60, health care workers and people with underlying medical conditions. By February, the ratio of COVID-19 patients aged 70 and older requiring mechanical ventilation declined 67% compared with that of patients under 50, the least vaccinated age group.

The authors said the findings provide preliminary evidence of the effectiveness of vaccines in preventing severe cases of COVID-19 in Israel.

Related News Articles

Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…